[Opposable medical references of the ANDEM concerning hyperlipidemia and its treatment].
BACKGROUND
Cardiovascular diseases are the main cause of morbidity and mortality in France, and frequently result from hyperlipidemia. Physicians are therefore often faced with the diagnosis and treatment of hyperlipidemia. However, this issue must be considered within the general context of the global vascular risk of a given subject.


BACKGROUND
Even though French health laws recently introduced do not take place of literature search to help guide the diagnosis and implement treatment, they may be considered as relevant summaries and guidelines with regard to current scientific knowledge. These laws mainly concern hypercholesterolemia and mixed hyperlipidemia and remind the physician that the patient's diet, values above which treatment is necessary and treatment objectives should be assessed before introducing any hypolipidemic treatment.


CONCLUSIONS
These new French laws are also an initial approach to treatment of hyperlipidemia, even though some ambiguities and issues are still unanswered. They should be considered as guidelines subject to modifications related to new findings.
D000328:Adult; D000367:Age Factors; D000368:Aged; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004032:Diet; D005260:Female; D005602:France; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D015228:Hypertriglyceridemia / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood